Asia-Pacific Americas Africa Europe Middle East

FORMOSA LABORATORIS INC

Company Profile:



Classification: Manufacturer (Factory)

Company Profile:

Formosa Laboratories Inc. is a leading pharmaceutical company based in Taiwan, specializing in the research, development, and manufacturing of Active Pharmaceutical Ingredients (APIs) and high-value chemical products. Established as a professional manufacturer, the company operates state-of-the-art production facilities that adhere to international quality standards, including cGMP certifications. Formosa Laboratories focuses on complex chemical synthesis and advanced manufacturing processes, serving global pharmaceutical markets by providing high-quality raw materials for drug formulations. Their core competencies include process development, regulatory support, and large-scale commercial production, positioning them as a key player in the global pharmaceutical supply chain.

Enterprise Products

FORMOSA LABORATORIES INC, based in Taiwan, manufactures and sells a variety of pharmaceutical products, primarily focusing on Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs). They also provide comprehensive Contract Development and Manufacturing Organization (CDMO) services.

Their main product categories and examples include:

1. Active Pharmaceutical Ingredients (APIs)

- Oncology APIs: Such as Paclitaxel, Gemcitabine HCl, Docetaxel Anhydrous, Capecitabine, Oxaliplatin.

- Anti-infective APIs: Including Azithromycin, Cefixime, Ciprofloxacin HCl, Sofosbuvir, Remdesivir.

- Central Nervous System (CNS) APIs: For example, Donepezil HCl, Rivastigmine Tartrate, Gabapentin, Pregabalin.

- Cardiovascular APIs: Such as Valsartan, Amlodipine Besylate, Rosuvastatin Calcium, Rivaroxaban.

- Metabolic Disorder APIs: Including Metformin HCl, Sitagliptin Phosphate, Empagliflozin, Insulin Glargine.

- Immunosuppressant APIs: Such as Tacrolimus, Mycophenolate Mofetil, Sirolimus, Cyclosporine.

- Anti-inflammatory APIs: For instance, Dexamethasone, Prednisone, Adalimumab, Rituximab.

- Other Therapeutic Areas: APIs for respiratory, gastrointestinal, and women's health.

2. Finished Dosage Forms (FDFs)

- Oral solid dosage forms: Tablets and Capsules.

- Injectable products: Vials and Lyophilized powders.

- Liquid preparations: Oral solutions and suspensions.

3. Contract Development and Manufacturing Organization (CDMO) Services

- Custom synthesis and manufacturing of APIs.

- Formulation development for various dosage forms.

- Analytical method development and validation.

- Manufacturing for clinical trial materials.

- Commercial scale manufacturing and supply.

Business Registration Information:

Manager:

Dr. M. C. Lin

Phone:

+886-3-598-3333

E-mail:

info@formosalabs.com

Official Website:
Address:

No. 16, Kung-Yeh 3rd Rd., Hsin-Chu Industrial Park, Hukou Hsiang, Hsinchu Hsien 30351, Taiwan, R.O.C.

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.